O	0	3	Use
O	4	6	of
O	7	8	a
B-intervention	9	17	decision
I-intervention	18	21	aid
O	22	31	including
O	32	43	information
O	44	46	on
O	47	60	overdetection
O	61	63	to
O	64	71	support
O	72	80	informed
O	81	87	choice
O	88	93	about
O	94	100	breast
O	101	107	cancer
O	108	117	screening
O	117	118	:
O	119	120	a
O	121	131	randomised
O	132	142	controlled
O	143	148	trial
O	148	149	.

O	150	161	Mammography
O	162	171	screening
O	172	175	can
O	176	182	reduce
O	183	189	breast
O	190	196	cancer
O	197	206	mortality
O	206	207	.

O	208	215	However
O	215	216	,
O	217	221	most
O	222	227	women
O	228	231	are
O	232	239	unaware
O	240	244	that
O	245	260	inconsequential
O	261	268	disease
O	269	272	can
O	273	277	also
O	278	280	be
O	281	289	detected
O	290	292	by
O	293	302	screening
O	302	303	,
O	304	311	leading
O	312	314	to
O	315	328	overdiagnosis
O	329	332	and
O	333	346	overtreatment
O	346	347	.

O	348	350	We
O	351	356	aimed
O	357	359	to
O	360	371	investigate
O	372	379	whether
O	380	389	including
O	390	401	information
O	402	407	about
O	408	421	overdetection
O	422	424	of
O	425	431	breast
O	432	438	cancer
O	439	441	in
O	442	443	a
O	444	452	decision
O	453	456	aid
O	457	462	would
O	463	467	help
O	468	473	women
O	474	478	aged
O	479	485	around
O	486	488	50
O	489	494	years
O	495	497	to
O	498	502	make
O	503	505	an
O	506	514	informed
O	515	521	choice
O	522	527	about
O	528	534	breast
O	535	544	screening
O	544	545	.

O	546	548	We
O	549	552	did
O	553	554	a
O	555	564	community
O	564	565	-
O	565	570	based
O	570	571	,
O	572	580	parallel
O	580	581	-
O	581	586	group
O	586	587	,
O	588	598	randomised
O	599	609	controlled
O	610	615	trial
O	616	618	in
B-location	619	622	New
I-location	623	628	South
I-location	629	634	Wales
I-location	634	635	,
I-location	636	645	Australia
O	645	646	,
O	647	652	using
O	653	654	a
O	655	661	random
O	662	668	cohort
O	669	671	of
O	672	677	women
O	678	682	aged
B-age	683	685	48
I-age	685	686	-
I-age	686	688	50
I-age	689	694	years
O	694	695	.

O	696	707	Recruitment
O	708	710	to
O	711	714	the
O	715	720	study
O	721	724	was
O	725	729	done
O	730	732	by
O	733	742	telephone
O	742	743	;
B-eligibility	744	749	women
I-eligibility	750	754	were
I-eligibility	755	763	eligible
I-eligibility	764	766	if
I-eligibility	767	771	they
I-eligibility	772	775	had
I-eligibility	776	779	not
I-eligibility	780	783	had
I-eligibility	784	795	mammography
I-eligibility	796	798	in
I-eligibility	799	802	the
I-eligibility	803	807	past
I-eligibility	808	809	2
I-eligibility	810	815	years
I-eligibility	816	819	and
I-eligibility	820	823	did
I-eligibility	824	827	not
I-eligibility	828	832	have
I-eligibility	833	834	a
I-eligibility	835	843	personal
I-eligibility	844	846	or
I-eligibility	847	853	strong
I-eligibility	854	860	family
I-eligibility	861	868	history
I-eligibility	869	871	of
I-eligibility	872	878	breast
I-eligibility	879	885	cancer
O	885	886	.

O	887	891	With
O	892	893	a
O	894	902	computer
O	903	910	program
O	910	911	,
O	912	914	we
O	915	923	randomly
O	924	932	assigned
B-total-participants	933	936	879
O	937	949	participants
O	950	952	to
O	953	959	either
O	960	963	the
O	964	976	intervention
O	977	985	decision
O	986	989	aid
O	990	991	(
O	991	1001	comprising
O	1002	1010	evidence
O	1010	1011	-
O	1011	1016	based
O	1017	1028	explanatory
O	1029	1032	and
O	1033	1045	quantitative
O	1046	1057	information
O	1058	1060	on
O	1061	1074	overdetection
O	1074	1075	,
O	1076	1082	breast
O	1083	1089	cancer
O	1090	1099	mortality
O	1100	1109	reduction
O	1109	1110	,
O	1111	1114	and
O	1115	1120	false
O	1121	1130	positives
O	1130	1131	)
O	1132	1134	or
O	1135	1136	a
O	1137	1144	control
O	1145	1153	decision
O	1154	1157	aid
O	1158	1159	(
O	1159	1168	including
O	1169	1180	information
O	1181	1183	on
O	1184	1190	breast
O	1191	1197	cancer
O	1198	1207	mortality
O	1208	1217	reduction
O	1218	1221	and
O	1222	1227	false
O	1228	1237	positives
O	1237	1238	)
O	1238	1239	.

O	1240	1252	Participants
O	1253	1256	and
O	1257	1269	interviewers
O	1270	1274	were
O	1275	1281	masked
O	1282	1284	to
O	1285	1290	group
O	1291	1301	assignment
O	1301	1302	.

O	1303	1306	The
O	1307	1314	primary
O	1315	1322	outcome
O	1323	1326	was
B-outcome-Measure	1327	1335	informed
I-outcome-Measure	1336	1342	choice
O	1343	1344	(
O	1344	1351	defined
O	1352	1354	as
O	1355	1363	adequate
O	1364	1373	knowledge
O	1374	1377	and
O	1378	1389	consistency
O	1390	1397	between
O	1398	1407	attitudes
O	1408	1411	and
O	1412	1421	screening
O	1422	1432	intentions
O	1432	1433	)
O	1433	1434	,
O	1435	1440	which
O	1441	1443	we
O	1444	1452	assessed
O	1453	1455	by
O	1456	1465	telephone
O	1466	1475	interview
O	1476	1481	about
O	1482	1483	3
O	1484	1489	weeks
O	1490	1495	after
O	1496	1502	random
O	1503	1513	allocation
O	1513	1514	.

O	1515	1518	The
O	1519	1526	primary
O	1527	1534	outcome
O	1535	1538	was
O	1539	1547	analysed
O	1548	1550	in
O	1551	1554	all
O	1555	1560	women
O	1561	1564	who
O	1565	1574	completed
O	1575	1578	the
O	1579	1587	relevant
O	1588	1594	follow
O	1594	1595	-
O	1595	1597	up
O	1598	1607	interview
O	1608	1617	questions
O	1618	1623	fully
O	1623	1624	.

O	1625	1629	This
O	1630	1635	trial
O	1636	1638	is
O	1639	1649	registered
O	1650	1654	with
O	1655	1658	the
O	1659	1669	Australian
O	1670	1673	New
O	1674	1681	Zealand
O	1682	1690	Clinical
O	1691	1697	Trials
O	1698	1706	Registry
O	1706	1707	,
O	1708	1714	number
O	1715	1734	ACTRN12613001035718
O	1734	1735	.

O	1736	1743	Between
O	1744	1751	January
O	1751	1752	,
O	1753	1757	2014
O	1757	1758	,
O	1759	1762	and
O	1763	1767	July
O	1767	1768	,
O	1769	1773	2014
O	1773	1774	,
B-intervention-participants	1775	1778	440
O	1779	1784	women
O	1785	1789	were
O	1790	1799	allocated
O	1800	1802	to
O	1803	1806	the
O	1807	1819	intervention
O	1820	1825	group
O	1826	1829	and
B-control-participants	1830	1833	439
O	1834	1838	were
O	1839	1847	assigned
O	1848	1850	to
O	1851	1854	the
B-control	1855	1862	control
I-control	1863	1868	group
O	1868	1869	.

O	1870	1872	21
O	1873	1878	women
O	1879	1881	in
O	1882	1885	the
O	1886	1898	intervention
O	1899	1904	group
O	1905	1908	and
O	1909	1911	20
O	1912	1920	controls
O	1921	1925	were
O	1926	1930	lost
O	1931	1933	to
O	1934	1940	follow
O	1940	1941	-
O	1941	1943	up
O	1943	1944	;
O	1945	1946	a
O	1947	1954	further
O	1955	1958	ten
O	1959	1964	women
O	1965	1973	assigned
O	1974	1976	to
O	1977	1980	the
O	1981	1993	intervention
O	1994	1997	and
O	1998	2000	11
O	2001	2009	controls
O	2010	2013	did
O	2014	2017	not
O	2018	2024	answer
O	2025	2028	all
O	2029	2038	questions
O	2039	2041	on
O	2042	2051	attitudes
O	2051	2052	.

O	2053	2062	Therefore
O	2062	2063	,
B-intervention-participants	2064	2067	409
O	2068	2073	women
O	2074	2076	in
O	2077	2080	the
O	2081	2093	intervention
O	2094	2099	group
O	2100	2103	and
B-control-participants	2104	2107	408
O	2108	2116	controls
O	2117	2121	were
O	2122	2130	analysed
O	2131	2134	for
O	2135	2138	the
O	2139	2146	primary
O	2147	2154	outcome
O	2154	2155	.

B-iv-bin-abs	2156	2158	99
O	2159	2160	(
B-iv-bin-percent	2160	2162	24
I-iv-bin-percent	2162	2163	%
O	2163	2164	)
O	2165	2167	of
B-intervention-participants	2168	2171	409
O	2172	2177	women
O	2178	2180	in
O	2181	2184	the
O	2185	2197	intervention
O	2198	2203	group
B-outcome	2204	2208	made
I-outcome	2209	2211	an
I-outcome	2212	2220	informed
I-outcome	2221	2227	choice
O	2228	2236	compared
O	2237	2241	with
B-cv-bin-abs	2242	2244	63
O	2245	2246	(
B-cv-bin-percent	2246	2248	15
I-cv-bin-percent	2248	2249	%
O	2249	2250	)
O	2251	2253	of
B-control-participants	2254	2257	408
O	2258	2260	in
O	2261	2264	the
O	2265	2272	control
O	2273	2278	group
O	2279	2280	(
O	2280	2290	difference
O	2291	2292	9
O	2292	2293	%
O	2293	2294	,
O	2295	2297	95
O	2297	2298	%
O	2299	2301	CI
O	2302	2303	3
O	2303	2304	-
O	2304	2306	14
O	2306	2307	;
O	2308	2309	p
O	2309	2310	=
O	2310	2311	0
O	2311	2312	·
O	2312	2316	0017
O	2316	2317	)
O	2317	2318	.

O	2319	2327	Compared
O	2328	2332	with
O	2333	2341	controls
O	2341	2342	,
O	2343	2347	more
O	2348	2353	women
O	2354	2356	in
O	2357	2360	the
O	2361	2373	intervention
O	2374	2379	group
B-outcome	2380	2383	met
I-outcome	2384	2387	the
I-outcome	2388	2397	threshold
I-outcome	2398	2401	for
I-outcome	2402	2410	adequate
I-outcome	2411	2418	overall
I-outcome	2419	2428	knowledge
O	2429	2430	(
B-iv-bin-abs	2430	2433	122
O	2433	2434	/
B-intervention-participants	2434	2437	419
O	2438	2439	[
B-iv-bin-percent	2439	2441	29
I-iv-bin-percent	2441	2442	%
O	2442	2443	]
O	2444	2446	vs
B-cv-bin-abs	2447	2449	71
O	2449	2450	/
B-control-participants	2450	2453	419
O	2454	2455	[
B-cv-bin-percent	2455	2457	17
I-cv-bin-percent	2457	2458	%
O	2458	2459	]
O	2459	2460	;
O	2461	2471	difference
O	2472	2474	12
O	2474	2475	%
O	2475	2476	,
O	2477	2479	95
O	2479	2480	%
O	2481	2483	CI
O	2484	2485	6
O	2485	2486	-
O	2486	2488	18
O	2488	2489	;
O	2490	2491	p
O	2491	2492	<
O	2492	2493	0
O	2493	2494	·
O	2494	2498	0001
O	2498	2499	)
O	2499	2500	,
O	2501	2506	fewer
O	2507	2512	women
O	2513	2522	expressed
B-outcome	2523	2531	positive
I-outcome	2532	2541	attitudes
I-outcome	2542	2549	towards
I-outcome	2550	2559	screening
O	2560	2561	(
B-iv-bin-abs	2561	2564	282
O	2564	2565	/
B-intervention-participants	2565	2568	409
O	2569	2570	[
B-iv-bin-percent	2570	2572	69
I-iv-bin-percent	2572	2573	%
O	2573	2574	]
O	2575	2577	vs
B-cv-bin-abs	2578	2581	340
O	2581	2582	/
B-control-participants	2582	2585	408
O	2586	2587	[
B-cv-bin-percent	2587	2589	83
I-cv-bin-percent	2589	2590	%
O	2590	2591	]
O	2591	2592	;
O	2593	2595	14
O	2595	2596	%
O	2596	2597	,
O	2598	2599	9
O	2599	2600	-
O	2600	2602	20
O	2602	2603	;
O	2604	2605	p
O	2605	2606	<
O	2606	2607	0
O	2607	2608	·
O	2608	2612	0001
O	2612	2613	)
O	2613	2614	,
O	2615	2618	and
O	2619	2624	fewer
O	2625	2630	women
B-outcome	2631	2639	intended
I-outcome	2640	2642	to
I-outcome	2643	2645	be
I-outcome	2646	2654	screened
O	2655	2656	(
B-iv-bin-abs	2656	2659	308
O	2659	2660	/
B-intervention-participants	2660	2663	419
O	2664	2665	[
B-iv-bin-percent	2665	2667	74
I-iv-bin-percent	2667	2668	%
O	2668	2669	]
O	2670	2672	vs
B-cv-bin-abs	2673	2676	363
O	2676	2677	/
B-control-participants	2677	2680	419
O	2681	2682	[
B-cv-bin-percent	2682	2684	87
I-cv-bin-percent	2684	2685	%
O	2685	2686	]
O	2686	2687	;
O	2688	2690	13
O	2690	2691	%
O	2691	2692	,
O	2693	2694	8
O	2694	2695	-
O	2695	2697	19
O	2697	2698	;
O	2699	2700	p
O	2700	2701	<
O	2701	2702	0
O	2702	2703	·
O	2703	2707	0001
O	2707	2708	)
O	2708	2709	.

O	2710	2714	When
O	2715	2725	conceptual
O	2726	2735	knowledge
O	2736	2741	alone
O	2742	2745	was
O	2746	2756	considered
O	2756	2757	,
B-iv-bin-abs	2758	2761	203
O	2762	2763	(
B-iv-bin-percent	2763	2765	50
I-iv-bin-percent	2765	2766	%
O	2766	2767	)
O	2768	2770	of
B-intervention-participants	2771	2774	409
O	2775	2780	women
O	2781	2783	in
O	2784	2787	the
O	2788	2800	intervention
O	2801	2806	group
B-outcome	2807	2811	made
I-outcome	2812	2814	an
I-outcome	2815	2823	informed
I-outcome	2824	2830	choice
O	2831	2839	compared
O	2840	2844	with
B-cv-bin-abs	2845	2847	79
O	2848	2849	(
B-cv-bin-percent	2849	2851	19
I-cv-bin-percent	2851	2852	%
O	2852	2853	)
O	2854	2856	of
B-control-participants	2857	2860	408
O	2861	2863	in
O	2864	2867	the
O	2868	2875	control
O	2876	2881	group
O	2882	2883	(
O	2883	2884	p
O	2884	2885	<
O	2885	2886	0
O	2886	2887	·
O	2887	2891	0001
O	2891	2892	)
O	2892	2893	.

O	2894	2905	Information
O	2906	2908	on
O	2909	2922	overdetection
O	2923	2925	of
O	2926	2932	breast
O	2933	2939	cancer
O	2940	2948	provided
O	2949	2955	within
O	2956	2957	a
O	2958	2966	decision
O	2967	2970	aid
O	2971	2980	increased
O	2981	2984	the
O	2985	2991	number
O	2992	2994	of
O	2995	3000	women
O	3001	3007	making
O	3008	3010	an
O	3011	3019	informed
O	3020	3026	choice
O	3027	3032	about
O	3033	3039	breast
O	3040	3049	screening
O	3049	3050	.

O	3051	3059	Becoming
O	3060	3066	better
O	3067	3075	informed
O	3076	3081	might
O	3082	3086	mean
O	3087	3092	women
O	3093	3096	are
O	3097	3101	less
O	3102	3108	likely
O	3109	3111	to
O	3112	3118	choose
O	3119	3128	screening
O	3128	3129	.

O	3130	3140	Australian
O	3141	3149	National
O	3150	3156	Health
O	3157	3160	and
O	3161	3168	Medical
O	3169	3177	Research
O	3178	3185	Council
O	3185	3186	.
